Clinical Trials Logo
  1. Home
  2. Masked Hypertension
  3. NCT02663336
  4. Details
NCT02663336 Clinical Trial

Prevalence of Masked Hypertension in Nephrological Patients

Masked Hypertension Clinical Trial

Official title:
Prevalence of Masked Hypertension in Nephrological Patients

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02663336
Other study ID # WaidBP16
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 2015
Est. completion date November 2023

Study information
Verified date October 2021
Source Waid City Hospital, Zurich
Contact Andreas Schleich
Phone -41 44 36621 11
Email Andreas.schleich@waid.zuerich.ch
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine the percentage of patients with masked hypertension in a population with chronic kidney disease. The investigators goal is to register prospectively ambulatory blood pressure measurement results of patients of a nephrological outpatient clinic with normal office blood pressure to finally find the percentage of masked hypertension in this population.

Recruitment information / eligibility
Status Recruiting
Enrollment 100
Est. completion date November 2023
Est. primary completion date January 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria: - Age: 20-90 years - Known arterial hypertension and antihypertensive medical treatment - Office blood pressure < 140 mmHg systolic and <90 mmHg diastolic Exclusion Criteria: - Age <20 or >90 years

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Comparison ABPM with OBPM
No interventions

Locations
Country Name City State
Switzerland Stadtspital Waid Zurich Zurich

Sponsors (1)
Lead Sponsor Collaborator
Waid City Hospital, Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number of participants with uncontrolled masked hypertension assessed by comparison of ambulatory blood pressure with office blood pressure 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT02804074 - MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement N/A
Active, not recruiting NCT02503943 - Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes Phase 4
Recruiting NCT02156024 - The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension Phase 4
Completed NCT02142881 - Treatment of Masked Hypertension Phase 3
Active, not recruiting NCT04200716 - Arterial Function After Two Different Physical Exercise Intensities in Prehypertension N/A
Not yet recruiting NCT05409898 - Screening for Masked Hypertension With Smart Wearable Devices (SMART)
Withdrawn NCT04121299 - Mechanism of Masked Hypertension - Intervention Phase 3
Active, not recruiting NCT02893358 - Antihypertensive Treatment in Masked Hypertension for Target Organ Protection Phase 4
Completed NCT04251975 - Masked Hypertensive Patients With Obstructive Sleep Apnea N/A